======= PDE7B ======= == Gene Information == * **Official Symbol**: PDE7B * **Official Name**: phosphodiesterase 7B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27115|27115]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NP56|Q9NP56]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PDE7B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PDE7B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604645|Open OMIM]] == Function Summary == * **Entrez Summary**: The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a cAMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family.[provided by RefSeq, Apr 2009]. * **UniProt Summary**: Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in the control of cAMP-mediated neural activity and cAMP metabolism in the brain. |PDEase I| |cAMP catabolic process| |3,5-cyclic-AMP phosphodiesterase activity| |cyclic nucleotide catabolic process| |cAMP metabolic process| |purine ribonucleotide catabolic process| |ribonucleotide catabolic process| |cyclic nucleotide metabolic process| |purine nucleotide catabolic process| |purine-containing compound catabolic process| |nucleotide catabolic process| |nucleoside phosphate catabolic process| |nucleobase-containing small molecule biosynthetic process| |organophosphate catabolic process| |carbohydrate derivative catabolic process| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |purine-containing compound metabolic process| |nucleobase-containing compound catabolic process| |chemical synaptic transmission| |anterograde trans-synaptic signaling| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |trans-synaptic signaling| |aromatic compound catabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |synaptic signaling| |organic cyclic compound catabolic process| |nucleobase-containing small molecule metabolic process| |small molecule biosynthetic process| |organophosphate metabolic process| |carbohydrate derivative metabolic process| |organonitrogen compound catabolic process| |nucleobase-containing compound biosynthetic process| |cell-cell signaling| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |G protein-coupled receptor signaling pathway| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|-2.1| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13846 * **Expression level (log2 read counts)**: 1.36 {{:chemogenomics:nalm6 dist.png?nolink |}}